UCSF has completed a license agreement with Elixir Pharmaceuticals, Inc. to provide the company access to aging-related genetics discoveries made by one of Elixir’s founders, Cynthia Kenyon, PhD, the Herbert Boyer Professor of Biochemistry and Biophysics at UCSF.